Ting Yao Selected Research

Ting Yao Research Topics

Disease

8	Neoplasms (Cancer) 05/2022 - 01/2009
6	Hepatocellular Carcinoma (Hepatoma) 10/2018 - 01/2009
5	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 09/2022 - 01/2021
5	Body Weight (Weight, Body) 01/2021 - 01/2017
5	Neoplasm Metastasis (Metastasis) 10/2018 - 01/2016
4	Obesity 01/2021 - 01/2017
3	Infections 05/2022 - 08/2020
3	Insulin Resistance 10/2020 - 01/2017
3	Carcinogenesis 07/2017 - 01/2016
2	Infarction (Infarctions) 10/2021 - 01/2017
2	Ischemic Stroke 10/2021 - 05/2014
2	Liver Neoplasms (Liver Cancer) 02/2018 - 08/2017
2	Brain Ischemia (Cerebral Ischemia) 01/2017 - 05/2014
2	Nervous System Diseases (Neurological Disorders) 11/2010 - 12/2007
1	Inflammation (Inflammations) 11/2022
1	Cognitive Dysfunction 06/2022
1	Primary Ovarian Insufficiency 05/2022
1	Hirschsprung Disease (Hirschsprung's Disease) 01/2022
1	Viremia 12/2021
1	Human Viral Hepatitis 12/2021
1	Hepatitis D 12/2021
1	Hemiplegia (Spastic Hemiplegia) 10/2021
1	Cerebellar Ataxia (Dysmetria) 07/2021
1	Spinocerebellar ataxia 20 07/2021
1	Hereditary Spastic Paraplegia 07/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 07/2021
1	Spinocerebellar Degenerations (Marinesco Sjogren Syndrome) 07/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021
1	Communicable Diseases (Infectious Diseases) 01/2020
1	Overnutrition 12/2019
1	Necrosis 05/2019
1	Trisomy (Trisomies) 05/2019
1	Hyperphagia (Overeating) 10/2017
1	Hearing Loss (Hearing Impairment) 06/2017
1	Liver Diseases (Liver Disease) 05/2017
1	Edema (Dropsy) 01/2017

Drug/Important Bio-Agent (IBA)

5	Circular RNAIBA 10/2018 - 05/2017
4	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 01/2021 - 01/2017
4	Proteins (Proteins, Gene)FDA Link 05/2017 - 12/2007
3	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2017
3	LeptinIBA 01/2021 - 01/2017
3	MicroRNAs (MicroRNA)IBA 08/2017 - 05/2017
3	ManganeseIBA 01/2011 - 12/2007
2	LuciferasesIBA 09/2022 - 01/2022
2	UbiquitinIBA 05/2022 - 12/2007
2	EnzymesIBA 05/2022 - 07/2021
2	Insulin (Novolin)FDA Link 01/2021 - 01/2017
2	Biomarkers (Surrogate Marker)IBA 10/2018 - 07/2017
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 02/2018 - 08/2017
2	Messenger RNA (mRNA)IBA 05/2017 - 11/2013
2	salicylhydroxamic acid (SHAM)IBA 01/2017 - 05/2014
2	kudieziIBA 01/2017 - 05/2014
1	Transcription Factors (Transcription Factor)IBA 11/2022
1	Interferon Regulatory FactorsIBA 11/2022
1	Caffeine (No Doz)FDA LinkGeneric 06/2022
1	1,7-dimethylxanthine (paraxanthine)IBA 06/2022
1	3-methylxanthineIBA 06/2022
1	1-methylxanthineIBA 06/2022
1	7-methylxanthineIBA 06/2022
1	Theophylline (Theon)FDA LinkGeneric 06/2022
1	Cisplatin (Platino)FDA LinkGeneric 05/2022
1	SuspensionsIBA 05/2022
1	MEF2 Transcription FactorsIBA 01/2022
1	Lysine (L-Lysine)FDA Link 01/2022
1	Histone DemethylasesIBA 01/2022
1	AntigensIBA 12/2021
1	Hepatitis delta Antigens (HDAg)IBA 12/2021
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 10/2021
1	ChloridesIBA 10/2021
1	SpastinIBA 07/2021
1	Valproic Acid (Depakote)FDA LinkGeneric 07/2021
1	Sorting NexinsIBA 07/2021
1	Protein Kinases (Protein Kinase)IBA 01/2021
1	Ionotropic Glutamate ReceptorsIBA 01/2021
1	celastrolIBA 01/2021
1	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	GlycogenIBA 10/2020
1	Triglycerides (Triacylglycerol)IBA 10/2020
1	Transaminases (Aminotransferases)IBA 08/2020
1	SesquiterpenesIBA 06/2020
1	zerumboneIBA 06/2020
1	Antiviral Agents (Antivirals)IBA 01/2020
1	Hormones (Hormone)IBA 12/2019
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 05/2019
1	MAP Kinase Kinase Kinase 4IBA 05/2019
1	cytochrome b245IBA 05/2019
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 05/2019
1	MelanocortinsIBA 10/2017
1	Biological ProductsIBA 10/2017
1	CorticosteroneIBA 03/2017
1	Proglucagon (Glucagon Precursors)IBA 03/2017

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 05/2022 - 01/2021
1	Therapeutics 12/2021
1	Aftercare (After-Treatment) 10/2021
1	Immunotherapy 01/2021
1	Activities of Daily Living (ADL) 06/2017